We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

48 hedge funds and large institutions have $577M invested in Myovant Sciences Ltd. in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

55% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 11

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

7% less capital invested

Capital invested by funds: $621M → $577M (-$44.3M)

8% less funds holding

Funds holding: 52 → 48 (-4)

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
17
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14.6M
2
RCM
RA Capital Management
Massachusetts
+$9.73M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.44M
4
EAM
Eventide Asset Management
Massachusetts
+$3.38M
5
BB
BB Biotech
Switzerland
+$1.26M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$10.2M
2
DM
Deerfield Management
New York
-$9.07M
3
Goldman Sachs
Goldman Sachs
New York
-$5.78M
4
PA
Perceptive Advisors
New York
-$2.81M
5
Norges Bank
Norges Bank
Norway
-$1.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$206K -$18.3K -1,593 -8%
Charles Schwab
27
Charles Schwab
California
$199K – – –
Wells Fargo
28
Wells Fargo
California
$194K +$146K +12,700 +332%
Morgan Stanley
29
Morgan Stanley
New York
$170K -$211K -18,440 -56%
TA
30
Teachers Advisors
New York
$135K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$130K +$127K +11,101 New
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$101K +$65.3K +5,696 +200%
AIG
33
American International Group
New York
$72K +$70.7K +6,166 New
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$49K +$47.6K +4,156 New
NFA
35
Nationwide Fund Advisors
Ohio
$44K +$42.7K +3,722 New
SO
36
STRS Ohio
Ohio
$39K – – –
Deutsche Bank
37
Deutsche Bank
Germany
$30K -$41.7K -3,635 -58%
Bank of America
38
Bank of America
North Carolina
$22K +$4.84K +422 +29%
PNC Financial Services Group
39
PNC Financial Services Group
Pennsylvania
$21K – – –
UBS Group
40
UBS Group
Switzerland
$20K -$14.7K -1,282 -42%
Legal & General Group
41
Legal & General Group
United Kingdom
$19K – – –
AIP
42
Ameritas Investment Partners
Nebraska
$11K +$10.3K +902 New
TRCT
43
Tower Research Capital (TRC)
New York
$4K +$2.52K +220 +220%
MAM
44
Meeder Asset Management
Ohio
$4K +$3.51K +306 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$3K -$3.88K -338 -60%
Citigroup
46
Citigroup
New York
$1K -$121K -10,590 -99%
Barclays
47
Barclays
United Kingdom
$1K -$653 -57 -29%
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$540 +$527 +46 New
SCM
49
Scopia Capital Management
New York
– -$10.2M -817,747 Closed
Goldman Sachs
50
Goldman Sachs
New York
– -$5.78M -464,635 Closed
1
2
3

MYOV Hedge Fund Activity: Q1 2017 in Review

48 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2017, worth a combined $577M — down 7.1% from $621M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MYOV positions and 9 closed out — a net gain of 1 holder — while 17 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $14.6M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $10.2M sold.

  • 48 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2017, down from 52 in Q4 2016.
  • Funds reported $577M of Myovant Sciences Ltd. stock for Q1 2017, down 7.1% quarter-over-quarter.
  • 10 funds opened new Myovant Sciences Ltd. positions in Q1 2017 and 9 closed out, a net change of +1 holder.
  • The largest Myovant Sciences Ltd. buyer in Q1 2017 was BlackRock, an estimated $14.6M added.
  • The largest Myovant Sciences Ltd. seller in Q1 2017 was Scopia Capital Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2017.